MedPath

ALCON RESEARCH

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Efficacy and Safety Study of FID 119515A

Not Applicable
Completed
Conditions
Dry Eye
Interventions
Other: Blink® Tears
Other: FID 119515A
First Posted Date
2013-04-16
Last Posted Date
2018-06-29
Lead Sponsor
Alcon Research
Target Recruit Count
75
Registration Number
NCT01833117

Silicone Hydrogel Contact Lens Clinical and Comfort Benefits With a Multi-Purpose Disinfecting Solution

Not Applicable
Completed
Conditions
Refractive Error
Presbyopia
Myopia
Hyperopia
Astigmatism
Interventions
Device: Lotrafilcon B contact lenses
Device: Senofilcon A contact lenses
Device: Habitual Multi-Purpose Solution (MPS)
Device: OPTI-FREE PureMoist Multi-Purpose Disinfecting Solution (MPDS)
First Posted Date
2013-03-12
Last Posted Date
2014-07-22
Lead Sponsor
Alcon Research
Target Recruit Count
387
Registration Number
NCT01809197

Clinical Evaluation of the Safety and Efficacy of a New Multifocal Contact Lens

Not Applicable
Completed
Conditions
Presbyopia
Myopia
Ametropia
Refractive Error
Interventions
Device: Nelfilcon A multifocal contact lens with comfort additive
Device: Nelfilcon A multifocal contact lens
First Posted Date
2013-02-25
Last Posted Date
2014-05-23
Lead Sponsor
Alcon Research
Target Recruit Count
83
Registration Number
NCT01797783

Efficacy and Safety Study of ESBA1008 Versus EYLEA®

Phase 2
Completed
Conditions
Exudative Age-Related Macular Degeneration
Interventions
Drug: ESBA1008 solution
First Posted Date
2013-02-22
Last Posted Date
2016-02-09
Lead Sponsor
Alcon Research
Target Recruit Count
173
Registration Number
NCT01796964

A Comparison of Two Color Contact Lenses in Habitual Clear Contact Lens Wearers

Not Applicable
Completed
Conditions
Myopia
Refractive Error
Interventions
Device: Lotrafilcon B contact lens with color
Device: Phemfilcon A contact lens with color
First Posted Date
2013-02-04
Last Posted Date
2014-05-09
Lead Sponsor
Alcon Research
Target Recruit Count
574
Registration Number
NCT01782482

Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis

Phase 3
Completed
Conditions
Allergic Conjunctivitis
Interventions
Drug: AL-4943A ophthalmic solution
Drug: AL-4943A ophthalmic solution vehicle
First Posted Date
2012-12-06
Last Posted Date
2014-08-11
Lead Sponsor
Alcon Research
Target Recruit Count
902
Registration Number
NCT01743027

SYSTANE® Family - Meibomian Deficiency

Not Applicable
Completed
Conditions
Dry Eye Syndrome
Interventions
Other: Microfiber towels (as warm compresses, with or without saline eye drops)
Other: SYSTANE® Lid Wipes
Other: SYSTANE® BALANCE
Dietary Supplement: SYSTANE® Vitamins
First Posted Date
2012-11-27
Last Posted Date
2018-06-29
Lead Sponsor
Alcon Research
Target Recruit Count
26
Registration Number
NCT01733745

SYSTANE® BALANCE Symptoms (OSDI) & Inflammatory Biomarkers

Not Applicable
Completed
Conditions
Dry Eye Syndrome
Interventions
Other: SYSTANE® Gel
Other: SYSTANE® BALANCE Lubricant Eye Drops
First Posted Date
2012-11-27
Last Posted Date
2018-06-29
Lead Sponsor
Alcon Research
Target Recruit Count
54
Registration Number
NCT01733732

The Effect of SYSTANE® BALANCE on Tear Film Break Up Time in Dry Eye Subjects

Not Applicable
Completed
Conditions
Dry Eye
Interventions
Other: Propylene glycol 0.6% ocular emulsion
Other: Sodium chloride 0.9% saline solution
First Posted Date
2012-10-31
Last Posted Date
2014-01-06
Lead Sponsor
Alcon Research
Target Recruit Count
51
Registration Number
NCT01718028
Locations
🇦🇷

Consultório Oftalmológico, Martinez, Buenos Aires, Argentina

Comparative In-Vivo Wetting Characteristics of Silicone Hydrogel Materials With Selected Lens Care Systems

Not Applicable
Completed
Conditions
Refractive Error
Myopia
Astigmatism
Interventions
Device: Lotrafilcon B contact lenses
Device: Senofilcon A contact lenses
Device: OPTI-FREE® PUREMOIST® MPDS
Device: BIOTRUE®
Device: Balafilcon A contact lenses
Device: ReNu® Multiplus®
First Posted Date
2012-10-04
Last Posted Date
2014-12-08
Lead Sponsor
Alcon Research
Target Recruit Count
109
Registration Number
NCT01699750
Locations
🇺🇸

Contact Alcon Call Center at 1-888-451-3937 for Trial Locations, Fort Worth, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath